US37045V1008 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 127.004B 3.69% | 156.735B 23.41% | 171.842B 9.64% | 180.759B 5.19% | |||||||
EBITDA YoY % growth | 27.975B 25.17% | 23.316B -16.65% | 22.233B -4.64% | 17.62B -20.75% | N/A | N/A | N/A | N/A | |||
EBIT YoY % growth | 15.924B 67.02% | 12.026B -24.48% | 10.345B -13.98% | 13.156B 27.17% | N/A | N/A | N/A | ||||
Operating Margin | 12.54% | 7.67% | 6.02% | 7.28% | N/A | N/A | N/A | ||||
EPS YoY % growth | 7.09 45.29% | 7.60 7.19% | 8.10 6.58% | 9.28 14.53% | N/A | N/A | N/A |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 2.43 2.62% | ||||||||||
Revenue Q2Q % growth | 45.902B 2.58% | ||||||||||
EBITDA Q2Q % growth | 4.651B | ||||||||||
EBIT Q2Q % growth | 3.412B 5.47% | N/A | N/A | N/A | N/A |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 2.62 18.55% | 2.21 | 0.41 | 18.69% |
Q4 2023 Q2Q % growth | 1.24 -41.51% | 1.20 | 0.04 | 3.73% |
Q3 2023 Q2Q % growth | 2.28 1.33% | 1.90 | 0.38 | 19.95% |
Q2 2023 Q2Q % growth | 2.37 107.89% | 1.91 | 0.46 | 24.10% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 43.014B 7.58% | 43.134B | -120M | -0.28% |
Q4 2023 Q2Q % growth | 42.979B -0.30% | 39.826B | 3.153B | 7.92% |
Q3 2023 Q2Q % growth | 44.131B 5.35% | 44.439B | -308M | -0.69% |
Q2 2023 Q2Q % growth | 44.746B 25.13% | 43.647B | 1.099B | 2.52% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 5.2% | 5.45% | 1.05% | 21.4% |
Revenue | 0.71% | 1.82% | -0.18% | 1.7% |